Legal Representation
Attorney
Lois Duquette
USPTO Deadlines
Next Deadline
1517 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240213)
Due Date
February 13, 2030
Grace Period Ends
August 13, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 13, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 13, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 25, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 21, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 21, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 19, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of the importance of vaccination and following health safety guidelines to prevent the spread of infectious diseases, namely, COVID-19
First Use Anywhere:
20200300
First Use in Commerce:
20200300
Class 044
Providing medical information relating to COVID-19
First Use Anywhere:
20200300
First Use in Commerce:
20200300
Additional Information
Pseudo Mark
BEAT COVID ONE NINE; BEAT COVID NINETEEN
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COVID-19"